Navigation Links
PDHI Launches Short Form of Its ConXus Profile Health Assessment
Date:3/16/2009

BERNARDSVILLE, N.J., March 16 /PRNewswire/ -- Protocol Driven Healthcare, Inc. (PDHI) now offers a short form of its health risk assessment (HRA), the ConXus(R) Profile. The shorter format facilitates completion by populations with low literacy and reduces processing costs of paper assessments. The short form does not replace the original, longer adult HRA, but joins PDHI's suite of ConXus applications, which includes assessments for students, children, and Spanish-speaking adults.

Employers can deliver both long and short forms to the same population or subgroup and can switch between long and short forms from year to year. Aggregate reports support both versions when deployed within the same population and time period.

"While the short-form HRA does not comply with NCQA HIP 1 or evalu8 standards, it does provide a robust option for employers to collect health data from hard-to-reach employees," said Jennifer Jolley, president of PDHI. "The abbreviated format also satisfies a request from many of our clients to deliver a solution that saves paper-processing costs while maintaining reporting integrity."

The short-form HRA includes about 40 instead of 70 questions. The user report shrinks to about 5 pages, and the paper questionnaire to 4 pages. The short form delivers all the functionality required to assess a participant's current health risk, omitting chronic and future disease risks on the long form.

The short-form HRA uses the same file structure as the long version, which simplifies ongoing version control. Both long and short versions of the HRA are available in English and Spanish and can be taken online or on paper.

Recent News

PDHI -- PDHI Adds Diabetes and Heart Disease Prevention to ConXus Steps Library of Action Plans http://www.pdhi.com/webnew/corporate/pressreleases/Diabetes.asp

PDHI - PDHI's Health Risk Appraisal and Consumer Health Tools Awarded NCQA HIP Certification

http://www.pdhi.com/webnew/corporate/pressreleases/NCQA.asp

About Protocol Driven Healthcare, Inc

PDHI is a healthcare technology and data processing organization that provides preventive health applications and services using the ConXus(R) health improvement platform. ConXus solutions are scalable and flexible, driving process efficiency and project control for clients. PDHI has adopted an open-systems approach, including extensive administrative tools and interfaces that allow integration of ConXus solutions into client portal environments. For more information, visit http://www.pdhi.com/.

    Contact:
    David Abel
    Vice President of Sales and Marketing
    908-315-0365, ext. 1026
    davida@pdhi.com

    Paul N. Greenwood
    Executive Vice President of Business Development
    515-277-1376, ext. 1224
    paulg@pdhi.com


'/>"/>
SOURCE Protocol Driven Healthcare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017 NetworkNewsWire Editorial Coverage  ... Cancer remains one ... on health care systems, in terms of costs and resources. ... does the development of innovative and efficient therapies that demonstrate ... many types of cancer treatments, a growing number of patients ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... , March 22, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage ... drug delivery systems, announced today that Dr. ... deliver a presentation titled, "Oral Insulin for Diabetes ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference ...
(Date:3/22/2017)... --  Boston Biomedical , an industry leader in the ... stemness pathways, today announced its Board of Directors has ... Officer, effective April 24, 2017. Ms. ... FACP, who has led Boston Biomedical since he founded ... Biomedical has grown from a "garage startup" without technology ...
Breaking Biology Technology:
(Date:3/20/2017)... 20, 2017 At this year,s CeBIT Chancellor Dr. ... manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with the ... year,s CeBIT partner country. At the largest German biometrics company the two ... face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/13/2017)... , March 13, 2017 Future of security: Biometric ... ... DERMALOGs Face Matching enables to match face pictures ... the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today announces that ... uncover insights to support its reporting, help direct future campaigns, and ... youth charity will be using Brandwatch Analytics social listening and analytics ... of the topics and issues that are a priority for its ... "Until recently ...
Breaking Biology News(10 mins):